DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer

被引：0
|
作者：
A Drouillard
F Puleo
J B Bachet
S Ouazzani
A Calomme
P Demetter
G Verset
J L Van Laethem
R Maréchal
机构：
[1] University Hospital of Dijon,Department of Gastroenterology and Digestive Oncology
[2] Digestive Cancer Registry of Burgundy,Department of Gastroenterology and Digestive Oncology
[3] INSERM U866,Department of Hepatogastroenterology
[4] University Hospital of Dijon,Department of Pathology
[5] Erasme Hospital,undefined
[6] Pitié Salpêtrière Hospital,undefined
[7] APHP,undefined
[8] Erasme Hospital,undefined
[9] Laboratory of Experimental Gastroenterology,undefined
[10] Université Libre de Bruxelles,undefined
来源：
British Journal of Cancer | 2016年 / 115卷
关键词：
DLL4; Notch1; Notch3; pancreatic cancer; biomarker; immunohistochemistry;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1245 / 1252
页数：7
相关论文
共 50 条
  • [31] The Prognostic Marker of Unresectable Pancreatic Cancer Undergoing Gemcitabine/nab-Paclitaxel Chemotherapy
    Ohno, A.
    Fujimori, N.
    Suehiro, Y.
    Murakami, M.
    Matsumoto, K.
    Teramatsu, K.
    Kojima, F.
    Takamaysu, Y.
    Takaoka, T.
    Oono, M.
    Ogawa, Y.
    PANCREAS, 2019, 48 (10) : 1500 - 1500
  • [32] A prognostic nomogram to predict the benefit of adjuvant radiotherapyfor resected inflammatory breast cancer patients.
    Ping, Yang Jun
    Nan, Qian Chao
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Clinical Significance of TAP1 and DLL4 Expression in Patients With Locally Advanced Gastric Cancer
    Segami, Kenki
    Aoyama, Toru
    Hiroshima, Yukihiko
    Komori, Keisuke
    Hashimoto, Itaru
    Watanabe, Hayato
    Kano, Kazuki
    Nagasawa, Shinsuke
    Nakazono, Masato
    Maezawa, Yukio
    Fujikawa, Hirohito
    Numata, Masakatsu
    Yamada, Takanobu
    Tamagawa, Hiroshi
    Yamamoto, Naoto
    Ogata, Takashi
    Siozawa, Manabu
    Yukawa, Norio
    Morinaga, Soichiro
    Rino, Yasushi
    Masuda, Munetaka
    Miyagi, Yohei
    Saeki, Hiroshi
    Oshima, Takashi
    IN VIVO, 2021, 35 (05): : 2771 - 2777
  • [34] PROGNOSTIC SIGNIFICANCE OF AUTOPHAGY-RELATED PROTEINS EXPRESSION IN RESECTED PANCREATIC CANCER
    Ko, Yoon Ho
    Cho, Young-Seok
    Won, Hye Sung
    Jeon, Eun Kyoung
    Lee, Myung Ah
    ANNALS OF ONCOLOGY, 2012, 23 : 60 - 60
  • [35] Intratumoural expression of dihydropyrimidine dehydrogenase is an independent prognostic factor in resected pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine
    Blomstrand, Hakon
    Bodarve, Malin
    Groth, Fredrik
    Naredi, Peter
    Sund, Malin
    Vilhav, Caroline
    Green, Henrik
    Bjornsson, Bergthor
    Ohlund, Daniel
    Lindblad, Stina
    Franklin, Oskar
    Elander, Nils O.
    ONCOLOGY LETTERS, 2025, 29 (02)
  • [36] Expression of integrin-linked kinase is not a useful prognostic marker in resected hepatocellular cancer
    Intaraprasong, Pongphob
    Assi, Kiran
    Owen, David A.
    Huntsman, David G.
    Chung, Stephen W.
    Scudamore, Charles H.
    Yoshida, Eric M.
    Salh, Baljinder
    ANTICANCER RESEARCH, 2007, 27 (6C) : 4371 - 4376
  • [37] Aberrant expression and association of VEGF and Dll4/Notch pathway molecules under hypoxia in patients with lung cancer
    Yu, Shuang
    Sun, Jianhua
    Zhang, Jingru
    Xu, Xingfang
    Li, Hong
    Shan, Baozhong
    Tian, Tian
    Wang, Hongchun
    Ma, Daoxin
    Ji, Chunyan
    HISTOLOGY AND HISTOPATHOLOGY, 2013, 28 (02) : 277 - 284
  • [38] HDAC5 promotes colorectal cancer cell proliferation by up-regulating DLL4 expression
    He, Ping
    Liang, Jiexiong
    Shao, Tiansong
    Guo, Yang
    Hou, Yingchen
    Li, Yang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (04): : 6510 - 6516
  • [39] Naples prognostic score may predict overall survival in metastatic pancreatic cancer
    Gulturk, Ilkay
    Yilmaz, Mesut
    Tacar, Seher Y.
    Bakkaloglu, Oguz K.
    Sonmezoz, Gulru B.
    Erdal, Gulcin S.
    Ozmen, Aykut
    Tural, Deniz
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20 (01) : 249 - 254
  • [40] MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer
    Lee, Sung Hwan
    Hwang, Ho Kyoung
    Lee, Woo Jung
    Kang, Chang Moo
    CELLULAR ONCOLOGY, 2021, 44 (06) : 1363 - 1371
12345